Review of ACC 2020 Late-Breaking Trials in Interventional Cardiology is a research paper published in Cardiovascular revascularization medicine (2020). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Mayo Clinic
National Institutes of Health
National Heart, Lung, and Blood Institute
Cardiovascular Research Foundation
Bayer Corporation
Janssen Pharmaceuticals
Biotronik
FWCI
0.14
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals